Does ENFORTUMAB VEDOTIN-EJFV Cause Malignant neoplasm progression? 410 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 410 reports of Malignant neoplasm progression have been filed in association with ENFORTUMAB VEDOTIN-EJFV. This represents 11.0% of all adverse event reports for ENFORTUMAB VEDOTIN-EJFV.
410
Reports of Malignant neoplasm progression with ENFORTUMAB VEDOTIN-EJFV
11.0%
of all ENFORTUMAB VEDOTIN-EJFV reports
137
Deaths
79
Hospitalizations
How Dangerous Is Malignant neoplasm progression From ENFORTUMAB VEDOTIN-EJFV?
Of the 410 reports, 137 (33.4%) resulted in death, 79 (19.3%) required hospitalization, and 9 (2.2%) were considered life-threatening.
Is Malignant neoplasm progression Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for ENFORTUMAB VEDOTIN-EJFV. However, 410 reports have been filed with the FAERS database.
What Other Side Effects Does ENFORTUMAB VEDOTIN-EJFV Cause?
Rash (560)
Neuropathy peripheral (410)
Fatigue (281)
Pruritus (260)
Diarrhoea (257)
Death (238)
Decreased appetite (230)
Off label use (193)
Alopecia (185)
Nausea (168)
What Other Drugs Cause Malignant neoplasm progression?
PEMBROLIZUMAB (10,111)
NIVOLUMAB (9,363)
ENZALUTAMIDE (4,696)
CARBOPLATIN (4,177)
EVEROLIMUS (3,789)
PACLITAXEL (3,484)
LETROZOLE (3,445)
IPILIMUMAB (3,296)
FULVESTRANT (3,221)
LENVATINIB (2,929)
Which ENFORTUMAB VEDOTIN-EJFV Alternatives Have Lower Malignant neoplasm progression Risk?
ENFORTUMAB VEDOTIN-EJFV vs ENFORTUMAB VEDOTIN\ENFORTUMAB VEDOTIN-EJFV
ENFORTUMAB VEDOTIN-EJFV vs ENFUVIRTIDE
ENFORTUMAB VEDOTIN-EJFV vs ENOXAPARIN
ENFORTUMAB VEDOTIN-EJFV vs ENOXAPARIN - WINTHROP
ENFORTUMAB VEDOTIN-EJFV vs ENSIFENTRINE